Bioceres Crop Solutions Corp.

NasdaqGS:BIOX Stock Report

Market Cap: US$421.7m

Bioceres Crop Solutions Past Earnings Performance

Past criteria checks 2/6

Bioceres Crop Solutions has been growing earnings at an average annual rate of 51.9%, while the Chemicals industry saw earnings growing at 9.7% annually. Revenues have been growing at an average rate of 25.1% per year. Bioceres Crop Solutions's return on equity is 1.8%, and it has net margins of 0.7%.

Key information

51.9%

Earnings growth rate

55.7%

EPS growth rate

Chemicals Industry Growth12.9%
Revenue growth rate25.1%
Return on equity1.8%
Net Margin0.7%
Next Earnings Update12 Nov 2024

Recent past performance updates

Recent updates

Take Care Before Jumping Onto Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Even Though It's 29% Cheaper

Sep 28
Take Care Before Jumping Onto Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Even Though It's 29% Cheaper

Bioceres' Q4 2024 Shows Challenges With HB4 Rollout, Still A Hold Despite Lower Stock Prices

Sep 17

These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively

Aug 03
These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively

Bioceres Needs To Add Clarity Around Borrowings

Mar 23

Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Feb 03
Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Oct 04
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Jun 21
Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

May 09
Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

Bioceres: A Resilient Small Cap With Conference Appearances After Thursday's Earnings

Sep 06

Bioceres Crop Solutions jumps 15% after investor pitch

Aug 23

We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Apr 10
We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Bioceres Has Not Resolved Its Major Risks And Is Growing Based On Commodities Bullishness

Mar 31

Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Mar 17
Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Nov 13
Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Jul 08
Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Jun 16
Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

May 26
What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

Bioceres partners with Havanna to offer consumers HB4 wheat-based sustainable products

May 10

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

May 05
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Apr 05
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Mar 10
Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Feb 12
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Revenue & Expenses Breakdown

How Bioceres Crop Solutions makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:BIOX Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24465310717
31 Mar 24446310616
31 Dec 234552210416
30 Sep 234091410216
30 Jun 23419199915
31 Mar 23416159513
31 Dec 22391-198811
30 Sep 22389-8789
30 Jun 22328-7657
31 Mar 22308-2587
31 Dec 212754526
30 Sep 212311466
30 Jun 21207-7456
31 Mar 21174-5374
31 Dec 20164-7354
30 Sep 201783344
30 Jun 201723334
31 Mar 201740365
31 Dec 19167-18365
30 Sep 19167-23364
30 Jun 19160-18344
31 Mar 19142-26293
31 Dec 18145-8283
30 Sep 18129-13294
30 Jun 18133-11314
30 Jun 1794-12274
31 Dec 1641-681
31 Dec 155-110

Quality Earnings: BIOX has high quality earnings.

Growing Profit Margin: BIOX's current net profit margins (0.7%) are lower than last year (4.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BIOX has become profitable over the past 5 years, growing earnings by 51.9% per year.

Accelerating Growth: BIOX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: BIOX had negative earnings growth (-82.7%) over the past year, making it difficult to compare to the Chemicals industry average (-5.8%).


Return on Equity

High ROE: BIOX's Return on Equity (1.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies